David Francis Sells 2,000 Shares of Maximus Inc. (MMS) Stock
Maximus Inc. (NYSE:MMS) General Counsel David Francis sold 2,000 shares of the stock in a transaction dated Friday, October 14th. The shares were sold at an average price of $55.00, for a total transaction of $110,000.00. Following the completion of the transaction, the general counsel now directly owns 29,616 shares in the company, valued at $1,628,880. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
David Francis also recently made the following trade(s):
- On Thursday, September 1st, David Francis sold 1,500 shares of Maximus stock. The stock was sold at an average price of $58.69, for a total transaction of $88,035.00.
- On Monday, August 1st, David Francis sold 1,500 shares of Maximus stock. The stock was sold at an average price of $58.91, for a total transaction of $88,365.00.
Shares of Maximus Inc. (NYSE:MMS) opened at 53.98 on Tuesday. The firm has a market cap of $3.50 billion, a price-to-earnings ratio of 22.06 and a beta of 1.15. Maximus Inc. has a 52-week low of $45.15 and a 52-week high of $69.85. The company’s 50 day moving average is $56.78 and its 200 day moving average is $55.98.
Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, August 4th. The company reported $0.75 EPS for the quarter, topping the consensus estimate of $0.71 by $0.04. The business had revenue of $617.10 million for the quarter, compared to analyst estimates of $625.62 million. Maximus had a net margin of 6.91% and a return on equity of 23.89%. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.62 earnings per share. Analysts anticipate that Maximus Inc. will post $2.65 earnings per share for the current year.
A number of brokerages have issued reports on MMS. Maxim Group increased their target price on shares of Maximus from $71.00 to $74.00 and gave the stock a “buy” rating in a research report on Thursday, August 4th. KeyCorp began coverage on shares of Maximus in a research report on Monday, July 11th. They set a “buy” rating on the stock. Finally, Zacks Investment Research lowered shares of Maximus from a “hold” rating to a “sell” rating in a research report on Wednesday, October 5th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. Maximus has a consensus rating of “Buy” and an average target price of $63.00.
A number of hedge funds have recently made changes to their positions in MMS. FMR LLC raised its stake in shares of Maximus by 17.4% in the second quarter. FMR LLC now owns 5,269,547 shares of the company’s stock valued at $291,775,000 after buying an additional 780,765 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Maximus by 67.5% in the first quarter. Goldman Sachs Group Inc. now owns 1,211,350 shares of the company’s stock valued at $63,765,000 after buying an additional 488,027 shares in the last quarter. FIL Ltd raised its stake in shares of Maximus by 171.8% in the second quarter. FIL Ltd now owns 716,824 shares of the company’s stock valued at $39,690,000 after buying an additional 453,116 shares in the last quarter. Makaira Partners LLC bought a new stake in shares of Maximus during the first quarter valued at approximately $23,251,000. Finally, Emerald Acquisition Ltd. bought a new stake in shares of Maximus during the second quarter valued at approximately $21,558,000. 99.00% of the stock is currently owned by institutional investors and hedge funds.
MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.